nivolumab,ipilimumab,cabozantinib
bms,exelixis
['nivo', 'triplet,(-triplete)', 'cosmic-313', 'ipilimumab', 'nivolumab']
#kidneycancer triplet slows progression in advanced disease when compared to immunotherapy combo (nivolumab + ipilimumab).
in this video, dana-farber's toni choueiri, md, ( ) has the latest data from cosmic-313 presented during #esmo22.
cc: 
Your official source for @DanaFarber Cancer Institute news | Research, science, and innovation | Media requests: media@dfci.harvard.edu or 617-632-4090